A team of University of Minnesota (U of M) researchers found that metformin, a drug commonly used to treat diabetes, can decrease the amount of COVID-19 virus in the body and lower the chances of the virus coming back strongly after initial treatment. The study was published in Clinical Infectious Diseases and former KL2 scholar Carolyn Bramante, M.D., M.P.H., is the principal investigator.
A higher viral load — the amount of virus in a person’s body — usually indicates a greater concentration of the virus, which can be important in understanding the severity of an infection and monitoring the effectiveness of treatments.
“The results of the study are important because COVID-19 continues to cause illness, both during acute infection and for months after infection,” said Dr. Bramante, an assistant professor at the U of M Medical School as well as an internist and pediatrician with M Health Fairview…
Read the full article here.
